Who invested in Coave Therapeutics

One round we have observed, with the 11 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechGenomics

Follow Coave Therapeutics and see its new rounds in your feed. Start following

Funding summaryUpdated 7 Nov 2026

$33Mraised across 1 round since 2025, from 2 sources

Latest round: Series A, $33MJan 2025
Led by: Bpifrance and Novo Holdings A/S
Investors: 11 (2 led)

See who backed them

The rounds

Jan 2025
Series A$33M
Reported by Seroba Life Sciences and 1 other

Founders and team

From Coave Therapeutics's own website: 4 on the team.

Annelise BrosselVice President of Regulatory and Translational Science
Alexandre SimonVP Head of Intellectual Property and Competitive intelligence
Julien BergerVP Legal Affairs and Corporate Secretary
Romain PettenaroVP Business Development

Everyone who backed them

BpifranceGovernment1round, led 1

Novo Holdings A/SGrowth equity1round, led 1

Novo HoldingsVC firm1round

Go CapitalVC firm1round

InvusPrivate equity1round

OmnesVC firm1round

KurmaPartnersVC firm1round

UI InvestissementPrivate equity1round

Turenne CapitalPrivate equity1round

Seroba Life SciencesVC firm1round

Fund+Company1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Coave Therapeutics

Who invested in Coave Therapeutics?

Coave Therapeutics's investors include Bpifrance, Novo Holdings A/S, Novo Holdings, Go Capital and Invus, and 6 more on record. Bpifrance led its latest round.